 |
Previous Article | Next Article 
Volume 17, Number 9,
Issue of May 1, 1997
pp. 3085-3095
Copyright ©1997 Society for Neuroscience
Dynamic Microtubule Ends Are Required for Growth Cone Turning to
Avoid an Inhibitory Guidance Cue
Jean F. Challacombe,
Diane M. Snow, and
Paul C. Letourneau
Department of Cell Biology and Neuroanatomy, The University of
Minnesota, Minneapolis, Minnesota 55455
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES
ABSTRACT
Growth cone turning is an important mechanism for changing
the direction of neurite elongation during development of the nervous system. Our previous study indicated that actin filament bundles at the
leading margin direct the distal microtubular cytoskeleton as growth
cones turn to avoid substratum-bound chondroitin sulfate proteoglycan.
Here, we investigated the role of microtubule dynamics in growth cone
turning by using low doses of vinblastine and taxol, treatments that
reduce dynamic growth and shrinkage of microtubule ends. We used
time-lapse phase-contrast videomicroscopy to observe embryonic chick
dorsal root ganglion neuronal growth cones as they encountered a border
between fibronectin and chondroitin sulfate proteoglycan in the
presence and absence of 4 nM vinblastine or 7 nM taxol. Growth cones were fixed and immunocytochemically labeled to identify actin filaments and microtubules containing tyrosinated and detyrosinated -tubulin.
Our results show that after contact with substratum-bound chondroitin
sulfate proteoglycan, vinblastine- and taxol-treated growth cones did
not turn, as did controls; instead, they stopped or sidestepped. Even
before drug-treated growth cones contacted a chondroitin sulfate
proteoglycan border, they were narrower than controls, and the distal
tyrosinated microtubules were less splayed and were closer to the
leading edges of the growth cones. We conclude that the splayed dynamic
distal ends of microtubules play a key role in the actin
filament-mediated steering of growth cone microtubules to produce
growth cone turning.
Key words:
microtubule;
growth cone;
turning;
actin filament;
chondroitin sulfate proteoglycan;
dynamic instability
INTRODUCTION
Growth cones are the motile tips of
elongating axons that guide growing axons to their targets during
development of the nervous system. Growth cone navigation involves the
detection and integration of extracellular signals, followed by a
response that can include forward migration, retraction, branching, and
turning. Detection of guidance cues is facilitated by protrusion and
retraction of filopodia and lamellipodia from the peripheral region
(P-domain) of the growth cone, which contains bundles and networks of
actin filaments (AFs) (Letourneau and Ressler, 1983 ; Lewis and
Bridgman, 1992 ). Axonal elongation depends on the advance of
microtubules (MTs), which provide structural support and serve as
tracks for axonal transport of membranous organelles. Stable MT bundles
project from the axon into the central region (C-domain) of the growth cone, whereas dynamic MT ends splay apart and project into the actin-rich P-domain (Letourneau and Ressler, 1983 ; Gordon-Weeks, 1991 ;
Challacombe et al., 1996 ).
Recent studies indicate that the advance of MTs into specific growth
cone regions initiates responses to guidance cues, such as advance
toward a target (Lin and Forscher, 1993 ), turning toward a positive cue
(Bentley and O'Connor, 1994 ), and turning away from an unfavorable
substratum (Tanaka and Kirschner, 1995 ) or inhibitory guidance cue
(Challacombe et al., 1996 ). Interactions between AFs and MTs may
regulate MT reorganization during these growth cone behaviors (Lin and
Forscher, 1993 ; Bentley and O'Connor, 1994 ; Challacombe et al.,
1996 ).
MTs are dynamic polymers, undergoing assembly and disassembly at their
ends. These events are regulated by the gain and loss of a GTP cap from
MT ends (Mitchison and Kirschner, 1984 ; Davis et al., 1994 ), the
tubulin isotype composition (Panda et al., 1994 ), stabilization of MTs
against loss of tubulin dimers (Bulinski and Gundersen, 1991 ), and
several MT-associated proteins (MAPs) (for review, see Avila et al.,
1994 ). In previous studies of MT dynamics, cells were treated with low
concentrations of tubulin-binding drugs that suppress the dynamic
instability of MT ends (Jordan et al., 1991 , 1992 , 1993 ; Zheng et al.,
1993 ; Liao et al., 1995 ; Tanaka et al., 1995 ; Yu and Baas, 1995 ;
Rochlin et al., 1996 ), showing that low concentrations of taxol,
vinblastine, and nocodazole reduce MT dynamics and decrease the rate of
neurite elongation (Letourneau and Ressler, 1984 ; Letourneau et al.,
1986 ; Zheng et al., 1993 ; Tanaka et al., 1995 ; Yu and Baas, 1995 ;
Rochlin et al., 1996 ).
Although these studies provide evidence that dynamic MTs are involved
in neurite elongation, no one has examined their role in growth cone
guidance. We used low concentrations of taxol and vinblastine to test
the hypothesis that dynamic MT ends are required for the selective
steering of MTs that is necessary for growth cone turning to avoid an
inhibitory guidance cue, chondroitin sulfate proteoglycan (CSPG). Our
results show that taxol and vinblastine partially reduced the rate of
neurite elongation and completely inhibited growth cone turning. These
findings indicate that splayed dynamic MT ends in the growth cone
P-domain are necessary for the redirection of MTs and initiation of
growth cone turning.
MATERIALS AND METHODS
Preparation of substrata. Heat-treated glass
coverslips (24 × 30 mm) were mounted over 22 mm holes drilled
into the bottom of 50 × 9 mm tissue culture dishes (Falcon
Labware, Oxnard, CA) using aquarium sealant (Dow-Corning, Midland, MI).
Coverslips were UV-sterilized for 30 min, coated with 0.1 mg/ml
poly-L-lysine for 1 hr at 40°C, rinsed, and coated with
nitrocellulose as described previously (Lagenaur and Lemmon, 1987 ; Snow
et al., 1990 ). Cellulose filter paper strips (Whatman No. 1) were
soaked in a solution of chick limb bud CSPG (a generous gift from Drs.
A. I. Caplan and D. A. Carrino, Case Western Reserve University,
Cleveland, OH) (Carrino and Kaplan, 1985 ) containing 20% rhodamine
isothiocyanate, transferred to nitrocellulose-coated dishes (Snow et
al., 1990 ), overlaid with 40-50 µg/ml human plasma fibronectin (FN)
(in PBS, pH 7.1; Life Technologies, Grand Island, NY), and incubated
for 3-4 hr at room temperature or overnight at 4°C. Dishes were
subsequently blocked with 5 mg/ml bovine serum albumin in PBS for 1 hr,
then covered with culture medium and stored at 40°C in a humidified air chamber.
Cell culture. Dorsal root ganglia (DRG) were dissected from
embryonic days 9-11 white Leghorn chicken embryos and cut into pieces
to make explants. Explants were suspended in supplemented serum-free
HEPES-buffered F14 medium (Letourneau et al., 1990 ). In some
experiments, dissociated DRG sensory neurons were used (Letourneau et
al., 1986 ). Dishes containing 20-25 explants or 20,000-30,000 sensory
neurons were incubated at 40°C in a humidified air chamber for 16-48
hr.
Videomicroscopy. After incubation, a culture dish was placed
on the stage of an inverted microscope (Diaphot, Nikon, Garden City,
NY) under an air curtain incubator (ASI 400, Carl Zeiss, Thornwood, NY)
at 40°C. Growth cones were viewed by phase-contrast optics while
rhodamine-labeled CSPG stripes were located under epi-illumination.
Time-lapse phase-contrast images were acquired with a Newvicon video
camera (Dage-MTI, Michigan City, IN) enhanced using Image 1 software
(Universal Imaging, West Chester, PA) and recorded with an optical disk
recorder (Panasonic TQ-2026F or TQ-3038F, Panasonic Industrial,
Secaucus, NJ).
Images of a microscope field containing several growth cones
approaching a CSPG stripe were recorded once per minute until the
growth cones were 100 µm from the CSPG border. Then culture medium
was replaced by medium containing either 7 nM taxol
(Natural Products Branch, National Cancer Institute, Bethesda, MD) or 4 nM vinblastine (Sigma, St. Louis, MO) diluted from stock
solutions dissolved in dimethyl sulfoxide (DMSO) at concentrations of
DMSO that did not exceed 3 µl/ml. A similar volume of DMSO alone was added to control cultures. Growth rates were calculated by measuring the distance that growth cones migrated (in micrometers) in successive recorded image frames using Image 1 software.
Fixation and immunocytochemistry. Cultures were fixed and
extracted simultaneously for 10 min with PHEM buffer (60 mM
PIPES, 25 mM HEPES, 10 mM EGTA, 2 mM MgCl2, pH 6.9) (Schliwa and van Blerkom,
1981 ; Letourneau and Ressler, 1983 ) containing 0.2% glutaraldehyde and
0.1% Triton X-100, followed by one 15 min treatment with 1 mg/ml
sodium borohydride in Ca2+-Mg2+-free PBS
(CMF-PBS) and incubation for 15 min in a soaking solution (consisting
of CMF-PBS containing 1% nonfat dry milk and 1 mg/ml sodium azide).
MTs were labeled with rat monoclonal antibody YL 1/2 directed against
tyrosinated -tubulin (Kilmartin et al., 1982 ) (Sera-Labs) and rabbit
polyclonal antibody against detyrosinated -tubulin (a generous gift
from Drs. J. C. Bulinski and G. G. Gundersen, Columbia University)
(Gundersen et al., 1984 ), used at 1:25 and 1:400 dilutions,
respectively. AFs were labeled with rhodamine-conjugated phalloidin
(Molecular Probes, Eugene, OR). Primary antibodies and phalloidin were
diluted into soaking solution and applied for 45 min. Dishes were
rinsed with CMF-PBS to remove unbound antibodies, then soaked for 15 min in soaking solution. Fluorescein- and CY5-conjugated secondary
antibodies (Jackson ImmunoResearch Laboratories, West Grove, PA),
at 1:400 dilutions, were applied simultaneously for 45 min. Dishes
were rinsed, soaked, and coverslipped in a solution containing
polyvinyl alcohol and glycerol.
Confocal microscopy. Immunofluorescence images were acquired
with either a BioRad MRC 1000 (Challacombe et al., 1996 ) or BioRad MRC
1024 confocal laser scanning microscope (BioRad Microscience, Cambridge, MA), equipped with an Olympus Provis AX70 microscope and
60× objective, and krypton-argon laser (Brelje et al., 1993 ). To
ensure that double- and triple-labeled images were in the greatest possible register, green, red, and/or far red fluorescence images were
acquired with the same dichroic mirror. Digital images were reproduced
using Adobe Photoshop version 3.0.
Quantitation of MT organization in growth cones. To
quantitatively examine the organization of MTs in taxol- and
vinblastine-treated growth cones, images of tyrosinated and
detyrosinated -tubulin labeling were merged with images of
phalloidin staining to view the positions of MTs within the growth cone
relative to the leading edge and filopodia. Distances from the leading
edge to the distal extents of both tyrosinated and detyrosinated MT
staining, and widths of the MT labeling and growth cone were measured
with BioRad MRC 1024 Laser Sharp software (version 2.1). For each
condition, measurement data were pooled, and differences were assessed
by either the Kruskal-Wallis test with post hoc multiple
comparison (Mosteller and Rourke, 1973 ; Conover, 1980 ) or the
Mann-Whitney test (Mosteller and Rourke, 1973 ).
RESULTS
Effects of taxol and vinblastine on growth cone
migration rate
Low concentrations of taxol and vinblastine have recently been
shown to be effective in reducing MT dynamics without dramatically affecting growth cone motility (Yu and Baas, 1995 ). In preliminary experiments, we determined that in the presence of 7 nM taxol or 4 nM vinblastine, DRG growth cones
continued to migrate, whereas 5- to 10-fold higher concentrations of
these drugs either stopped growth cone migration or caused neurite
retraction. To ascertain whether 4 nM vinblastine and 7 nM taxol had substantial effects on DRG growth cone
migration and neurite elongation, we examined time-lapse video
recordings and calculated the migration rates of a sample of growth
cones over a 15-60 min period before addition of the drug, during drug
treatment, and after washout of the drug. In a separate series of
experiments, we determined the rate of growth cone migration on
homogeneous FN in the presence of control medium containing DMSO
vehicle alone. The mean growth cone migration rates in micrometers per
hour are shown in Table 1. Compared with the
pre-vinblastine and DMSO control migration rates, growth cones migrated
33-35% slower during vinblastine treatment, and growth cone migration
did not fully recover during the 1-2 hr period after vinblastine
washout. For taxol-treated growth cones, the mean migration rates
before taxol treatment, in the presence of 7 nM taxol, and
after washout were not significantly different.
Table 1.
Rates of growth cone migration in the presence of low
concentrations of taxol and
vinblastine
| Treatment |
Growth cone migration
rate (no. of growth cones) |
|
| DMSO
control |
45.1
± 5.5 (18) |
| Pre-taxol |
39.9 ± 4.2 (26) |
| 7 nM
taxol |
39.1 ± 3.2 (42) |
| Taxol washout |
40.8
± 3.2 (16) |
| Pre-vinblastine |
43.9 ± 3.6 (30) |
| 4
nM vinblastine |
29.6
± 1.5 (78)a |
| Vinblastine washout |
25.7
± 2.9 (22)a |
|
|
Growth cone migration rates were calculated by measuring the
distances individual growth cones migrated (in micrometers) over a
15-60 min period. Rates were expressed as µm/hr ± SEM. Differences in growth cone migration rates among all groups were assessed by the
Kruskal-Wallis test with post hoc multiple comparison.
a
Significantly slower than pre-vinblastine rate
(p < 0.05).
|
|
Taxol and vinblastine prevent growth cone turning
To assess the role of MT dynamics in growth cone turning, we
examined the behavior of growth cones in the presence and absence of
vinblastine and taxol using our in vitro guidance assay, a substratum composed of alternating stripes of FN and CSPG (Snow et al.,
1990 ; Challacombe et al., 1996 ). Growth cones that were migrating on
homogeneous FN were recorded once per minute as they approached CSPG
borders. At a distance of 50-100 µm from a border, either taxol or
vinblastine was added, and the growth cones were recorded as they
advanced and then contacted CSPG, and for an additional period of up to
4 hr after first contact. This time period was chosen because 83% of
control growth cones that turn will do so within approximately 2 hr of
initial contact with the CSPG border (Challacombe et al., 1996 ). The
behaviors of vinblastine- and taxol-treated growth cones at FN/CSPG
borders are shown in Table 2. Whereas 61% of control
growth cones turned to avoid CSPG and migrated along the border
(Challacombe et al., 1996 ), growth cones treated with the drugs did not
turn. Drug-treated growth cones at CSPG borders were recorded for
periods of 4-6 hr or overnight. Many vinblastine- and taxol-treated
growth cones underwent alternating periods of stopping, brief
retractions, and lateral movement (sidestepping) along the CSPG border.
During these behaviors, growth cone filopodia sampled the CSPG by
protruding, waving, bending, and retracting in a manner similar to that
of control growth cones (Snow et al., 1991 , 1994 ; Challacombe et al.,
1996 ). Figure 1 shows phase-contrast sequences of growth cones exhibiting normal turning behavior (A-D), stopping in
the presence of vinblastine (E-H), and
stopping/sidestepping in the presence of taxol (I-L). In a
separate series of experiments, we determined whether
vinblastine- and taxol-treated growth cones that had been stopped
or sidestepping at CSPG borders for at least 1 hr would return to
normal behavior after drug washout. Results indicate that 75% of
growth cones exposed to vinblastine and 57% of growth cones exposed to
taxol turned within 1-2 hr after drug washout (data not shown). Taken
together, these results show that low concentrations of vinblastine and
taxol, which reduce MT dynamics, completely prevent growth cone
turning. Furthermore, the effects of these drugs on growth cone turning
are reversible.
Table 2.
Effects of taxol and vinblastine on growth cone behavior at
FN/CSPG borders
| Treatment |
Stopped |
Sidestepped |
Turned |
Combinations
of stopped/ retracted/ sidestepped |
Misc.a |
|
| DMSO
controlb |
0% |
17% (4) |
61% (14) |
0% |
22% (5)c |
| Taxol
(7 nM) |
11.1% (2) |
16.7% (3) |
0% |
66.7% (12) |
5.5% (1)d |
| Vinblastine
(4 nM) |
23.8% (5) |
9.5% (2) |
0% |
57.2% (12) |
9.5% (2)e |
|
Growth cone behaviors at FN/CSPG borders were categorized by
reviewing video records of growth cones that approached, then contacted, a CSPG stripe. Growth cones were observed for several hours
after first contact with CSPG. For each treatment, growth cone
behaviors at FN/CSPG borders were noted. The number of growth cones
exhibiting each behavior is given in parentheses.
a
Misc., Miscellaneous.
b
Data for DMSO controls from Challacombe et al.
(1996) .
c
Five growth cones exhibited intermittent
periods of stopping, sidestepping, and turning.
d
One growth cone crossed the border after more
than 4 hr in the presence of 7 nM taxol.
e
Two growth cones branched at the border, then
both branches sidestepped.
|
|
Fig. 1.
Phase-contrast video sequences showing a control
growth cone that turned to avoid a CSPG border compared with
vinblastine- and taxol-treated growth cones that failed to turn.
A-D, Turning control growth cone. E-H,
Growth cone that stopped at the border in the presence of 4 nM vinblastine. I-L, 7 nM
taxol-treated growth cone that sidestepped and stopped at the CSPG
border. Arrowheads in I-L mark the
position of the taxol-treated growth cone at the border and show that
it sidestepped laterally along the border for a short distance. All
three sequences include the first filopodial contact with CSPG
(A, E, I) followed by C-domain advance to the FN/CSPG border (B, F, J), continued filopodial
sampling of the CSPG stripe (C, G, K), and either
turning (control; D) or continued interaction with the
border (drug-treated; H, L). Drug-treated growth cones
did not turn, even after interacting with the CSPG border for periods
of 4-6 hr or overnight. For each sequence, the time interval after
first filopodial contact is shown in the subsequent frames. Scale bar,
10 µm.
[View Larger Version of this Image (118K GIF file)]
Taxol and vinblastine alter MT organization
Because low concentrations of vinblastine and taxol prevented
growth cone turning, we examined the organization of MTs and AFs in
recorded growth cones that were migrating on homogeneous FN or at a
CSPG border. To obtain fluorescent images of the cytoskeleton in the
previously recorded growth cones, culture dishes were fixed and
immunocytochemically labeled with fluorescent phalloidin and with
antibodies directed against tyrosinated and detyrosinated -tubulin,
and confocal images were acquired as described previously (Challacombe
et al., 1996 ). Detyrosination is a post-translational modification of
-tubulin, carried out by a tubulin-specific carboxypeptidase that
acts on the tubulin subunits within MTs. The reverse reaction, tyrosination, is performed by tubulin tyrosine ligase, which acts on
soluble tubulin subunits (for review, see Bulinski and Gundersen, 1991 ). As MT polymers persist in cells, they stain more strongly with
antibodies against detyrosinated -tubulin and become less reactive
with antibodies against tyrosinated -tubulin; thus, antibodies
directed against these two different tubulin isotypes can be used to
distinguish between older and newer MTs (Gundersen et al., 1984 ;
Webster et al., 1987 ; Baas and Black, 1990 ; Arregui et al., 1991 ; Baas
et al., 1993 ; Brown et al., 1993 ). In this report, we refer to MTs
stained with antityrosinated -tubulin antibodies as Tyr-MTs, and
those labeled with antibodies directed against detyrosinated
-tubulin as Detyr-MTs.
When untreated DRG growth cones migrate on homogeneous FN, the MT
bundle extends throughout the C-domain, and individual Tyr-MTs splay
into the P-domain where they overlap with AF bundles at the bases of
filopodia. In contrast to controls, in vinblastine- and taxol-treated
growth cones migrating on homogeneous FN, Tyr-MTs were less splayed
throughout the growth cone (Fig. 2). In control growth
cones migrating on FN, phalloidin-labeled AFs were present at the
leading edge and extended as bundles within filopodia (Fig. 2A), whereas the ends of Tyr-MTs (Fig.
2B) projected into the P-domain, overlapping with AFs
at the bases of filopodia. Detyr-MTs were confined to the C-domain
where some of them formed loops (Fig. 2C). In growth cones
treated with 4 nM vinblastine (Fig. 2D)
and 7 nM taxol (Fig. 2G), phalloidin-labeled AFs
were present at the leading edge and in filopodia. However, Tyr-MTs
(Fig. 2E,H, arrows) were less splayed than in
control growth cones as they extended forward into the AF-rich
P-domain. Another difference between control and drug-treated growth
cones was that in control growth cones, Detyr-MTs formed loops in the
C-domain (Fig. 2C), whereas in vinblastine- (Fig.
2F) and taxol-treated (Fig. 2I) growth cones, such looped Detyr-MTs were less prevalent. In growth cones migrating on FN and exposed to vinblastine or taxol for 1-2 hr
followed by washout of the drugs for 1-2 hr (Fig.
2J-L), the MTs were even more splayed than in
controls. In a representative growth cone exposed to vinblastine, which
was subsequently washed out, phalloidin-labeled AFs were present at the
leading edge (Fig. 2J), the ends of Tyr-MTs were
widely splayed throughout the P-domain (Fig. 2K), and
Detyr-MTs formed loops in the C-domain (Fig. 2L).
Fig. 2.
Comparison of AF and MT organization in chick DRG
growth cones migrating on FN in the presence and absence of 4 nM vinblastine and 7 nM taxol. A, D, G,
J, Phalloidin-labeled AFs. B, E, H, K, Tyrosinated -tubulin labeling. C, F, I, L,
Detyrosinated -tubulin labeling. A-C, Control growth
cone. D-F, A growth cone exposed to 4 nM
vinblastine. G-I, A growth cone treated with 7 nM taxol. J-L, A growth cone exposed to 4 nM vinblastine, which was subsequently washed out.
Arrows in E and H point to
the bundled MTs that stained with antibodies directed against
tyrosinated -tubulin, showing that the Tyr-MT ends in the
vinblastine- and taxol-treated growth cones are less splayed than those
in the control growth cone. Scale bar, 10 µm.
[View Larger Version of this Image (69K GIF file)]
Figure 3 compares the organization of AFs and MTs in a
control growth cone turning at a CSPG border with vinblastine- and taxol-treated growth cones that were either stopped or sidestepping at
a CSPG border. In the turning control growth cone (Fig.
3A-C), the ends of Tyr-MTs (Fig. 3B) and
Detyr-MTs (Fig. 3C) are bundled and turned to be aligned
along the border, with Tyr-MT ends projecting into the bases of AF-rich
filopodia at the growth cone tip (see also Fig.
4D). The arrangement of MTs and AFs in
vinblastine- and taxol-treated growth cones at a CSPG border is shown
in Figure 3D-I. The organization of Tyr-MTs (Fig.
3E,H) and Detyr-MTs (Fig. 3F,I)
within the growth cones is similar to the MT organization in the
drug-treated growth cones migrating on FN (Fig.
2E,F,H,I).
Fig. 3.
Comparison of AF and MT organization in chick DRG
growth cones at a CSPG border in the presence and absence of 4 nM vinblastine and 7 nM taxol. A, D,
G, Phalloidin-labeled AFs. B, E, H, Tyrosinated -tubulin labeling. C, F, I, Detyrosinated -tubulin
labeling. A-C, A control growth cone turning to avoid
growing on CSPG. D-F, A growth cone exposed to 4 nM vinblastine that has contacted the CSPG border.
G-I, A growth cone treated with 7 nM taxol
that is stopped at the border. The CSPG border is shown in A,
D, and G. In G, the border was
digitally enhanced to make it more visible. Vinblastine- and
taxol-treated growth cones do not turn to avoid CSPG, but instead stop,
retract, or sidestep laterally along the border. Arrows
in E and H show that, in drug-treated
growth cones at CSPG borders, the organization of Tyr-MTs is similar to
that of drug-treated growth cones migrating on FN (see Fig. 2). Scale bar, 10 µm.
[View Larger Version of this Image (144K GIF file)]
Fig. 4.
Merged three-color images showing the organization
of AFs and MTs in growth cones migrating on FN and at CSPG borders in
the presence and absence of vinblastine and taxol. A-C
correspond to Figure 2, and D-F correspond to Figure 3.
In F, the CSPG border was digitally enhanced to make it
more visible. In all panels, AF labeling is blue,
tyrosinated -tubulin labeling is red, and detyrosinated -tubulin labeling is green. The close
proximity of Tyr-MTs (red) to AFs (blue)
is apparent in all growth cones, as is the reduced splaying of Tyr-MT
ends in growth cones exposed to vinblastine and taxol. These color
images also demonstrate that the organization of MTs in drug-treated
growth cones at CSPG borders is similar to those migrating on FN. Scale
bar, 10 µm.
[View Larger Version of this Image (111K GIF file)]
A more direct comparison of the MT distribution between
vinblastine- and taxol-treated growth cones and controls can be made by
examining the three-color images in Figure 4. A-C
correspond to Figure 2, and D-F correspond to Figure
3. The splaying and close proximity of Tyr-MT ends (red) to
AFs (blue) are apparent in the control growth cones (Fig.
4A,D), as is the reduced splaying of Tyr-MT ends
(red) in the vinblastine- (Fig. 4B) and
taxol-treated (Fig. 4C) growth cones migrating on FN. Figure
4 also illustrates the bundling and turning of the MTs in the control
growth cone that was turning at a CSPG border (Fig.
4D), whereas the configuration of Tyr-MTs in the
vinblastine- (Fig. 4E) and taxol-treated (Fig. 4F) growth cones that were not turning is similar to
that of drug-treated growth cones migrating on FN.
Quantitative analysis of MT organization in vinblastine-
and taxol-treated growth cones
In a previous study, we quantitatively analyzed the organization
of Tyr-MTs, Detyr-MTs, and AFs in turning growth cones and in growth
cones that failed to turn after treatment with cytochalasin B
(Challacombe et al., 1996 ). In this study, we used a similar technique
to examine the organization of Tyr-MTs and Detyr-MTs in the presence of
taxol and vinblastine. We measured and compared several parameters in
growth cones migrating on homogeneous FN and at CSPG borders: (1)
distance from the leading edge, excluding filopodia, to distal ends of
Tyr-MT staining; (2) distance from leading edge to distal extents of
Detyr-MT staining; (3) width of Tyr-MT staining at the widest point;
(4) width of Detyr-MT staining at the widest point; and (5) width of
the growth cone at the widest point. The schematic in Figure
5 illustrates how measurements 1-4 were made. The width
of the growth cone was measured across the widest point, excluding
filopodia.
Fig. 5.
Schematic diagram of a growth cone illustrating
how measurements of MT organization were made. Detyr-MTs are shown in
black, and Tyr-MT ends are gray.
Measurements from the leading edge (excluding filopodia) to the distal
extents of Tyr-MTs and Detyr-MTs are depicted by the thin black
double-headed arrows marked a and
b, respectively. The width of the Tyr-MT ends is
represented by a thicker black double-headed arrow
(c), and the width of Detyr-MT staining is illustrated
by a white double-headed arrow (d). The width of the growth cone (not marked) was from side to side at the
widest point, excluding filopodia.
[View Larger Version of this Image (17K GIF file)]
Results of this analysis (Table 3) showed that,
for growth cones migrating on homogeneous FN, the mean widths of Tyr-MT
staining in vinblastine- and taxol-treated growth cones were
significantly decreased compared with control growth cones. In
addition, the mean growth cone widths also decreased. These results
indicate that under the influence of vinblastine and taxol, the distal Tyr-MT ends are significantly less splayed in the P-domain, and the
growth cones are narrower than control growth cones. Vinblastine and
taxol treatment also resulted in a significant decrease in the distance
from the leading edge to the distal extents of Tyr-MTs but not
Detyr-MTs, indicating that the distance between the distal extents of
Tyr- and Detyr-MTs was greater than in controls. However, the distal
limit of detyrosination may not indicate the limit of MT stability in
the presence of these drugs, because the Tyr-MT ends may become
stabilized before Tyr-tubulin is accessible to the enzyme responsible
for detyrosination. A significant observation was that when taxol and
vinblastine were washed out, growth cones became significantly wider
than even the control growth cones, and the splayed width of Tyr-MT
ends was also increased significantly beyond controls. This observation
supports a link between the dynamic growth and shrinkage of the distal
MT ends and a splayed MT distribution in the P-domain of growth
cones.
Table 3.
Quantitation of MT organization in growth cones migrating
on FN and interacting with a CSPG border in the presence and absence of
4 nM vinblastine and 7 nM
taxol
| Substratum |
Treatment |
Leading edge to
Tyr-MTs |
Leading edge to
Detyr-MTs |
Width Tyr-MTs |
Width Detyr-MTs |
Width growth
cone |
|
| Homogeneous |
Control |
5.63
± 0.34 |
9.10 ± 0.40 |
7.85 ± 0.89 |
4.01
± 0.58 |
16.44
± 1.50 |
| FN |
|
(178) |
(150) |
(45) |
(44) |
(43) |
|
4
nM |
3.04 ± 0.54* |
9.3 ± 0.78 |
3.85
± 0.54* |
2.43 ± 0.23 |
7.47
± 1.03* |
|
vinblastine |
(20) |
(20) |
(15) |
(15) |
(15) |
|
7
nM taxol |
2.57 ± 0.50* |
8.72 ± 0.77 |
2.88
± 0.44* |
3.14 ± 0.60 |
7.83
± 1.01* |
|
|
(16) |
(16) |
(15) |
(17) |
(15) |
|
Vinblastine |
3.77
± 0.69 |
7.80 ± 0.96 |
13.64 ± 2.90** |
8.84
± 2.31** |
22.94
± 3.06** |
|
washout |
(23) |
(22) |
(11) |
(11) |
(11) |
|
Taxol |
4.28
± 0.54 |
9.37 ± 0.67 |
13.73 ± 2.38** |
7.37
± 1.24** |
26.86
± 2.51** |
|
washout |
(27) |
(25) |
(10) |
(10) |
(10) |
|
| CSPG
border |
Control |
4.66 ± 0.38 |
7.94 ± 0.49 |
4.39
± 0.46 |
2.17 ± 0.20 |
9.25
± 0.97 |
|
turning |
(107) |
(92) |
(41) |
(41) |
(41) |
|
4
nM |
1.76 ± 0.50* |
6.80 ± 0.65 |
3.80
± 0.59 |
2.46 ± 0.29 |
8.27
± 1.10 |
|
vinblastine |
(20) |
(20) |
(21) |
(21) |
(19) |
|
7
nM taxol |
1.72 ± 0.65* |
6.22 ± 0.75 |
5.01
± 1.59 |
3.61 ± 1.17 |
7.63
± 0.91 |
|
|
(20) |
(20) |
(15) |
(15) |
(13) |
|
|
The measurement categories represent mean ± SEM distances in
micrometers. For each substratum, the Kruskal-Wallis test with post hoc multiple comparison was used to assess the
significance of differences between the distributions of measurements
in each category.
*
p < 0.05, significantly different from
control.
**
p < 0.05, significantly different from all other
groups.
|
|
Table 3 also shows a similar analysis of these MT parameters in
growth cones at a CSPG border. Controls were turning, and vinblastine-
and taxol-treated growth cones were either stopped at a border or
sidestepping along it before fixation. Results of this analysis show
that the altered MT organization induced by vinblastine and taxol
treatment persists in growth cones interacting with a CSPG border. The
distance from the leading edge to Tyr-MTs is significantly smaller than
in controls, and the distance from the leading edge to Detyr-MTs is
similar to controls. Furthermore, the widths of Tyr- and Detyr-MT
staining, as well as the widths of drug-treated growth cones, are
similar to controls. One of the key changes in growth cone morphology
and MT organization that occurs during normal turning behavior is the
bundling of the MT ends and narrowing of the growth cone (Tanaka and
Kirschner, 1995 ; Challacombe et al., 1996 ). Our present findings show
that for growth cones on homogeneous FN, the width of distal Tyr-MT staining and the growth cone width of control and drug-treated growth
cones are significantly different, whereas in growth cones at a CSPG
border, there are no differences in these parameters. Taken together,
these results indicate that in vinblastine- and taxol-treated growth
cones, Tyr-MT ends are less splayed and are closer to the leading edge
while the growth cones are migrating on homogeneous FN, and the MT
organization remains that way at a CSPG border, where the growth cones
fail to turn.
DISCUSSION
The goal of this study was to examine the role of dynamic MTs in
growth cone turning by using low concentrations of vinblastine and
taxol. Vinblastine and taxol are unrelated plant metabolites that
suppress MT dynamics at low substoichiometric concentrations, although
they bind to different sites on MTs (Jordan et al., 1991 , 1993 ).
Experiments in vitro showed that taxol concentrations as low
as 10 nM decreased both shrinking and growing events at MT ends (Derry et al., 1995 ). Experiments in vivo using HeLa
cells showed that 8 nM taxol and 0.8 nM
vinblastine inhibited mitosis by 50% without inducing significant
depolymerization of MTs (Jordan et al., 1991 , 1993 ). These results
indicate that very low concentrations of taxol and vinblastine
are effective in suppressing MT dynamics in cells. Thus, we used taxol
and vinblastine to reduce the dynamics of MT ends in DRG growth cones
and investigate the role of dynamic MTs in growth cone turning.
When control growth cones migrate to and contact a CSPG border,
they turn or stop to avoid crossing the border (Challacombe et al.,
1996 ). When we applied 7 nM taxol or 4 nM
vinblastine while growth cones were approaching a CSPG border, the
growth cones continued to migrate toward the border, although the rate of migration was reduced by 4 nM vinblastine. Once at the
border, none of the drug-treated growth cones turned. Instead, growth cones either stopped at the border, sidestepped laterally along the
border, or exhibited a combination of behaviors that included intermittent pausing, retraction, and sidestepping without turning. Filopodia and lamellipodia continued to be actively protruded along and
across the border by the drug-treated growth cones, but the growth
cones never turned at the border.
Previous studies used low concentrations of MT-specific drugs to
investigate the role of dynamic MTs in neurite elongation. Low doses of
vinblastine and nocodazole inhibited axonal elongation from
Xenopus neural tube (Tanaka et al., 1995 ) and rat superior cervical ganglion neurons (Rochlin et al., 1996 ). In contrast, we found
that chick DRG neurites elongated in the presence of low concentrations
of vinblastine and taxol, and a similar study showed that chick DRG
neurites elongated when net MT assembly was inhibited by 4 nM vinblastine (Yu and Baas, 1995 ). These results indicate
that MT translocation alone can support the elongation of DRG neurites.
This conflicts with previous studies of fluorescence recovery after
photobleaching of fluorescent MTs (Lim et al., 1990 ; Edson et al.,
1993 ), which found that MT translocation is not significant along chick
DRG neurites. However, these previous studies also found that
fluorescence recovery was rapid in the distal neurite near the growth
cone (Edson et al., 1993 ), and perhaps localized MT translocation at
the distal neurite can support growth cone migration and neurite
elongation for some time in the presence of anti-MT drugs.
Our results do show that dynamic MTs in the growth cone are
needed for responses to guidance cues, such as turning away from CSPG.
In support of this idea, observations of MT ends in living cells
indicate that MT polymerization is responsible, at least in part, for
advancing MTs from the growth cone C-domain into the P-domain (Tanaka
et al., 1995 ; Miller and Joshi, 1996 ). A model for growth cone steering
suggests that these MT ends in the P-domain are the pioneers of axonal
growth that lead the advance of other MTs and neuritic components
(Sabry et al., 1991 ; Tanaka and Kirschner, 1991 ; Lin and Forscher,
1993 ; Bentley and O'Connor, 1994 ; Tanaka and Kirschner, 1995 ). Recent
evidence indicates that dynamic MTs play a role in growth cone turning
at a laminin/tenascin border in vitro (Williamson et al.,
1996 ). We propose that a key event in growth cone turning or branching
may be the capture or stabilization of dynamic MT ends at one side of
the growth cone via their interactions with AF bundles of lamellipodia
and filopodia (Letourneau and Ressler, 1983 ; Forscher and Smith, 1988 ;
Gordon-Weeks, 1991 ; Tanaka and Kirschner, 1991 ; Lin and Forscher, 1993 ;
Challacombe et al., 1996 ). In a previous study, we tested this
hypothesis with the AF-depolymerizing drug cytochalasin B and found
that, in the absence of AF bundles, MT ends in the P-domain were widely splayed. When such growth cones reached a border with a repulsive substratum, the MTs were not steered to one side to initiate growth cone turning (Challacombe et al., 1996 ). Our present results provide substantial evidence in support of the idea that dynamic MT ends are
required for growth cone turning to avoid an inhibitory guidance cue.
Our observations and measurements revealed two major differences in the
distribution of MTs between taxol- and vinblastine-treated growth cones
and control growth cones on homogeneous FN. The ends of Tyr-MTs were
closer to the leading growth cone margin and were less splayed than in
control growth cones. In addition, drug-treated growth cones were
narrower than controls.
Our data indicate that vinblastine- and taxol-treated growth
cones fail to turn because their MT organization is altered such that
MTs are not steered to one side. How does the reduction in MT dynamics
by vinblastine and taxol interfere with the MT rearrangements that are
crucial for growth cone turning? One possibility is that, because the
MTs of vinblastine- and taxol-treated growth cones are less splayed in
the P-domain, the MT ends may not interact to a sufficient degree with
AF bundles, and are therefore not steered to one side to initiate a
growth cone turn (Fig. 6).
Fig. 6.
A, A model for growth cone
turning. In a growth cone migrating on homogeneous FN, stable MTs
(black) are bundled in the neurite by the activity of
MAPs (striped rectangles) and extend into the C-domain,
whereas dynamic MT ends (gray) splay throughout
the P-domain. Some dynamic MT ends are linked to AF bundles (thin black lines) at the bases of filopodia by an unknown linkage
molecule (filled circles). When the growth cone
contacts a CSPG border, filopodia sample the CSPG, but these are
unstable contacts. Some filopodia remain on FN, forming more stable
contacts with the substratum. When the AF bundles of these filopodia
are linked to dynamic MT ends, the AF bundles steer the dynamic MT ends
asymmetrically along the border to initiate the turn. During turning,
the growth cone MTs become bundled and aligned along the border.
B, A growth cone that fails to turn in the presence of
low concentrations of taxol or vinblastine. In a growth cone treated
with taxol or vinblastine, the MT ends in the P-domain are less dynamic
and become less splayed while the growth cone is migrating on FN. When
the growth cone contacts a CSPG border, filopodia sample the CSPG but
the distal MTs remain less splayed in the P-domain, the MT ends are not
steered by AFs, and the growth cone fails to turn. This may be
attributable to a premature stabilization and stiffening of the MT ends
in the P-domain, resulting either directly from drug-induced changes in
MT properties or from increased binding of MAPs to the less dynamic
MTs. The failure to turn also may be because of an inability of the
linkage molecule to connect AFs to the less dynamic MT ends.
[View Larger Version of this Image (53K GIF file)]
The reduced dynamics of these MT ends may lead to a premature
stabilization and stiffening of the MT ends in the P-domain, so they
assume the bundled configuration that is seen in the C-domain and more
proximal growth cone (Fig. 6B). This reduced splaying of the MT ends may result either directly from drug-induced changes in
MT properties (Mickey and Howard, 1995 ; Feigner et al., 1996 ) or
perhaps from facilitated binding of MAPs to the less dynamic MT ends
(Black, 1987 ; Chapin et al., 1991 ; Chapin and Bulinski, 1992 ; Dreschel
et al., 1992 ; Matus, 1994 ; Heidemann, 1996 ). As a result, the pull
exerted by AFs cannot overcome the increased stiffness and interactions
between the MT ends.
Based on results from other studies of the effects of MT drugs on
cell motility, we suggest that another contribution to the inhibition
of growth cone turning by these drugs is that dynamic MT ends are
necessary for active remodeling of AF networks in the growth cone
P-domain. Bershadsky et al. (1991) showed that MT-binding drugs reduced
the protrusive activity of fibroblasts by acting on MT organization and
not by a direct action on actin. Our findings that drug-treated growth
cones are narrower, and that Tyr-MTs are closer to the leading edge
suggest that vinblastine and taxol reduced the size of the P-domain.
Similarly, our previous study also showed that the filopodia of
taxol-treated growth cones extended across a narrower range of angles
than control growth cone filopodia (Letourneau et al., 1986 ).
Therefore, the effects of vinblastine and taxol on MT dynamics may have
indirectly reduced the tension and ability of AFs to pull on MT ends in
the P-domain.
We noted that when taxol and vinblastine were removed from the culture
medium of growth cones migrating on FN, the distal Tyr-MT ends
recovered and became widely splayed in the P-domain, and growth cones
were wider than control growth cones. This result supports our
hypothesis that the splayed configuration of MT ends in the P-domain of
growth cones on FN requires dynamic MT ends (but not AF bundles,
because cytochalasin B-treated growth cones contain widely splayed MTs)
(Challacombe et al., 1996 ).
In summary, we found that low concentrations of taxol and vinblastine,
which reduce MT dynamics, prevent DRG growth cone turning. These
results support the hypothesis proposed by Tanaka et al. (1995) , that
dynamic MT ends play a key role in the MT rearrangements that
occur during growth cone migration and axonal elongation. Furthermore,
we provide important new data suggesting that dynamic MT ends are
necessary for the MT rearrangements in the P-domain that underlie
growth cone turning. Taken together with our previous finding that AF
bundles direct MT bundling and reorientation during turning
(Challacombe et al., 1996 ), our present results suggest that chick DRG
growth cone turning to avoid CSPG depends on the presence of dynamic MT
ends in the P-domain, where they splay and are captured by filopodial
AFs (Fig. 6A). The steering of these dynamic MT ends
to one side leads to the asymmetric alignment of MTs as the growth cone
turns along the CSPG border.
FOOTNOTES
Received Nov. 7, 1996; revised Feb. 5, 1997; accepted Feb. 10, 1997.
This work was supported by National Institutes of Health Grants HD19950
(P.C.L.), F32-NS09971 (J.F.C.), and EY10545 (D.M.S.), and the Minnesota
Medical Foundation. We thank Dr. G. Gallo for suggestions on this
manuscript, Drs. A. I. Caplan and D. A. Carrino for their generous gift
of chick limb bud CSPG, and Drs. J. C. Bulinski and G. G. Gundersen for
providing antiserum against detyrosinated -tubulin.
Correspondence should be addressed to Jean F. Challacombe, Department
of Cell Biology and Neuroanatomy, The University of Minnesota, 4-144 Jackson Hall, 321 Church Street SE, Minneapolis, MN 55455.
Dr. Snow's present address: Department of Anatomy and Neurobiology,
The University of Kentucky, Lexington, KY 40536.
REFERENCES
-
Arregui C,
Busciglio A,
Caceres A,
Barra HS
(1991)
Tyrosinated and detyrosinated microtubules in axonal processes of cerebellar macroneurons grown in culture.
J Neurosci Res
28:171-181[Web of Science][Medline].
-
Avila J,
Dominguez J,
Diaz-Nido J
(1994)
Regulation of microtubule dynamics by microtubule-associated protein expression and phosphorylation during neuronal development.
Int J Dev Biol
38:13-25[Web of Science][Medline].
-
Baas PW,
Black MM
(1990)
Individual microtubules in the axon consist of domains that differ in both composition and stability.
J Cell Biol
111:495-509[Abstract/Free Full Text].
-
Baas PW,
Ahmad FJ,
Pienkowski TP,
Brown A,
Black MM
(1993)
Sites of microtubule stabilization for the axon.
J Neurosci
13:2177-2185[Abstract].
-
Bentley D,
O'Connor TP
(1994)
Cytoskeletal events in growth cone steering.
Curr Opin Neurobiol
4:43-48[Medline].
-
Bershadsky AD,
Vaisberg EA,
Vasiliev JM
(1991)
Pseudopodial activity at the active edge of migrating fibroblasts is decreased after drug-induced microtubule depolymerization.
Cell Motil Cytoskeleton
19:152-158[Web of Science][Medline].
-
Black MM
(1987)
Taxol interferes with the interaction of microtubule-associated proteins with microtubules in cultured neurons.
J Neurosci
7:3695-3702[Abstract].
-
Brelje TC,
Wessendorf MW,
Sorenson RL
(1993)
Multicolor laser scanning confocal immunofluorescence microscopy: practical applications and limitations.
Methods Cell Biol
38:97-181[Web of Science][Medline].
-
Brown A,
Li Y,
Slaughter T,
Black MM
(1993)
Composite microtubules of the axon: quantitative analysis of tyrosinated and acetylated tubulin along individual axons.
J Cell Sci
104:339-352[Abstract].
-
Bulinski JC,
Gundersen GG
(1991)
Stabilization and post-translational modification of microtubules during cellular morphogenesis.
BioEssays
13:285-292[Web of Science][Medline].
-
Carrino DA,
Kaplan AI
(1985)
Isolation and characterization of proteoglycans synthesized in ovo by embryonic chick cartilage and new bone.
J Biol Chem
260:122-127[Abstract/Free Full Text].
-
Challacombe JF,
Snow DM,
Letourneau PC
(1996)
Actin filament bundles are required for microtubule reorientation during growth cone turning to avoid an inhibitory guidance cue.
J Cell Sci
109:2031-2040[Abstract].
-
Chapin SJ,
Bulinski JC
(1992)
Microtubule stabilization by assembly-promoting microtubule-associated proteins: a repeat performance.
Cell Motil Cytoskeleton
23:236-243[Web of Science][Medline].
-
Chapin SJ,
Bulinski JC,
Gundersen GG
(1991)
Microtubule bundling in cells.
Nature
349:24[Medline].
-
Conover WJ
(1980)
In: Practical nonparametric statistics, 2nd Ed. New York: Wiley.
-
Davis A,
Sage CR,
Dougherty CA,
Farrell KW
(1994)
Microtubule dynamics modulated by guanosine triphosphate hydrolysis activity of
-tubulin.
Science
264:839-841[Abstract/Free Full Text]. -
Derry WB,
Wilson L,
Jordan MA
(1995)
Substoichiometric binding of taxol suppresses microtubule dynamics.
Biochemistry
34:2203-2211[Medline].
-
Dreschel DN,
Hyman AA,
Cobb MH,
Kirschner MW
(1992)
Modulation of the dynamic instability of tubulin by the microtubule-associated protein tau.
Mol Biol Cell
3:1141-1154[Abstract].
-
Edson KJ,
Lim S-S,
Borisy GG,
Letourneau PC
(1993)
FRAP analysis of the stability of the microtubule population along the neurites of chick sensory neurons.
Cell Motil Cytoskeleton
25:59-72[Web of Science][Medline].
-
Feigner H,
Frank R,
Schliwa M
(1996)
Flexural rigidity of microtubules measured with the use of optical tweezers.
J Cell Sci
109:509-516[Abstract].
-
Forscher P,
Smith SJ
(1988)
Actions of cytochalasins on the organization of actin filaments and microtubules in a neuronal growth cone.
J Cell Biol
107:1505-1516[Abstract/Free Full Text].
-
Gordon-Weeks PR
(1991)
Evidence for microtubule capture by filopodial actin filaments in growth cones.
NeuroReport
2:573-576[Web of Science][Medline].
-
Gundersen GG,
Kalnoski MH,
Bulinski JC
(1984)
Distinct populations of microtubules: tyrosinated and nontyrosinated alpha tubulin are distributed differently in vivo.
Cell
38:779-789[Web of Science][Medline].
-
Heidemann SR
(1996)
Cytoplasmic mechanisms of axonal and dendritic growth in neurons.
Int Rev Cytol
165:235-296[Web of Science][Medline].
-
Jordan MA,
Thrower D,
Wilson L
(1991)
Mechanism of inhibition of cell proliferation by vinca alkaloids.
Cancer Res
51:2212-2222[Abstract/Free Full Text].
-
Jordan MA,
Thrower D,
Wilson L
(1992)
Effects of vinblastine, podophyllotoxin and nocodazole on mitotic spindles. Implications for the role of microtubule dynamics in mitosis.
J Cell Sci
102:401-416[Abstract/Free Full Text].
-
Jordan MA,
Toso RJ,
Thrower D,
Wilson L
(1993)
Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations.
Proc Natl Acad Sci USA
90:9552-9556[Abstract/Free Full Text].
-
Kilmartin JV,
Wright B,
Milstein D
(1982)
Rat monoclonal antitubulin antibodies derived using a new non-secretory rat cell line.
J Cell Biol
9:3576-3582.
-
Lagenaur C,
Lemmon V
(1987)
An L1-like molecule, the 8D9 antigen, is a potent substrate for neurite extension.
Proc Natl Acad Sci USA
84:7753-7757[Abstract/Free Full Text].
-
Letourneau PC,
Ressler AH
(1983)
Differences in the organization of actin in the growth cones compared with the neurites of cultured neurons from chick embryos.
J Cell Biol
97:963-973[Abstract/Free Full Text].
-
Letourneau PC,
Ressler AH
(1984)
Inhibition of neurite initiation and growth by taxol.
J Cell Biol
98:1355-1362[Abstract/Free Full Text].
-
Letourneau PC,
Shattuck TA,
Ressler AH
(1986)
Branching of sensory and sympathetic neurites in vitro is inhibited by treatment with taxol.
J Neurosci
6:1912-1917[Abstract].
-
Letourneau PC,
Shattuck TA,
Roche FK,
Takeichi M,
Lemmon V
(1990)
Nerve growth cone migration onto Schwann cells involves the calcium-dependent adhesion molecule, N-cadherin.
Dev Biol
138:430-442[Web of Science][Medline].
-
Lewis AK,
Bridgman PC
(1992)
Nerve growth cone lamellipodia contain two populations of actin filaments that differ in organization and polarity.
J Cell Biol
119:1219-1243[Abstract/Free Full Text].
-
Liao G,
Nagasaki T,
Gundersen GG
(1995)
Low concentrations of nocodazole interfere with fibroblast locomotion without significantly affecting microtubule level: implications for the role of dynamic microtubules in cell locomotion.
J Cell Sci
108:3473-3483[Abstract].
-
Lim S-S,
Edson KJ,
Letourneau PC,
Borisy GG
(1990)
A test of microtubule translocation during neurite elongation.
J Cell Biol
111:123-130[Abstract/Free Full Text].
-
Lin C-H,
Forscher P
(1993)
Cytoskeletal remodeling during growth cone-target interactions.
J Cell Biol
121:1369-1383[Abstract/Free Full Text].
-
Matus A
(1994)
Stiff microtubules and neuronal morphology.
Trends Neurosci
17:19-22[Web of Science][Medline].
-
Mickey B,
Howard J
(1995)
Rigidity of microtubules is increased by stabilizing agents.
J Cell Biol
130:909-917[Abstract/Free Full Text].
-
Miller KE,
Joshi HC
(1996)
Tubulin transport in neurons.
J Cell Biol
133:1355-1366[Abstract/Free Full Text].
-
Mitchison T,
Kirschner M
(1984)
Dynamic instability of microtubule growth.
Nature
312:237-242[Medline].
-
Mosteller F,
Rourke REK
(1973)
In: Sturdy statistics. Nonparametrics and order statistics. Reading, MA: Addison-Wesley.
-
Panda D,
Miller HP,
Banerjee A,
Luduena RF,
Wilson L
(1994)
Microtubule dynamics in vitro are regulated by the tubulin isotype composition.
Proc Natl Acad Sci USA
91:11358-11362[Abstract/Free Full Text].
-
Rochlin MW,
Wickline KM,
Bridgman PC
(1996)
Microtubule stability decreases axon elongation but not axoplasm production.
J Neurosci
16:3236-3246[Abstract/Free Full Text].
-
Sabry JH,
O'Connor TP,
Evans L,
Toroian-Raymond A,
Kirschner M,
Bentley D
(1991)
Microtubule behavior during guidance of pioneer neuron growth cones in situ.
J Cell Biol
115:381-395[Abstract/Free Full Text].
-
Schliwa M,
van Blerkom J
(1981)
Structural interaction of cytoskeletal components.
J Cell Biol
90:222-235[Abstract/Free Full Text].
-
Snow DM,
Lemmon V,
Carrino DA,
Caplan AI,
Silver J
(1990)
Sulfated proteoglycans in astroglial barriers inhibit neurite outgrowth in vitro.
Exp Neurol
109:111-130[Web of Science][Medline].
-
Snow DM,
Watanabe M,
Letourneau PC,
Silver J
(1991)
A chondroitin sulfate proteoglycan may influence the direction of retinal ganglion cell outgrowth.
Development
113:1473-1485[Abstract].
-
Snow DM,
Atkinson PB,
Hassinger TD,
Letourneau PC,
Kater SB
(1994)
Chondroitin sulfate proteoglycan elevates cytoplasmic calcium in DRG neurons.
Dev Biol
166:87-100[Web of Science][Medline].
-
Tanaka EM,
Kirschner MW
(1991)
Microtubule behavior in the growth cones of living neurons during axon elongation.
J Cell Biol
115:345-363[Abstract/Free Full Text].
-
Tanaka EM,
Kirschner MW
(1995)
The role of microtubules in growth cone turning at substrate boundaries.
J Cell Biol
128:127-137[Abstract/Free Full Text].
-
Tanaka EM,
Ho T,
Kirschner MW
(1995)
The role of microtubule dynamics in growth cone motility and axonal growth.
J Cell Biol
128:139-155[Abstract/Free Full Text].
-
Webster DR,
Gundersen GG,
Bulinski JC,
Borisy GG
(1987)
Differential turnover of tyrosinated and detyrosinated microtubules.
Proc Natl Acad Sci USA
84:9040-9044[Abstract/Free Full Text].
-
Williamson T,
Gordon-Weeks PR,
Schachner M,
Taylor J
(1996)
Microtubule reorganization is obligatory for growth cone turning.
Proc Natl Acad Sci USA
93:15221-15226[Abstract/Free Full Text].
-
Yu W,
Baas PW
(1995)
The growth of the axon is not dependent upon net microtubule assembly at its distal tip.
J Neurosci
15:6827-6833[Abstract/Free Full Text].
-
Zheng J,
Buxbaum RE,
Heidemann SR
(1993)
Investigation of microtubule assembly and organization accompanying tension-induced neurite initiation.
J Cell Sci
104:1239-1250[Abstract].
This article has been cited by other articles:

|
 |

|
 |
 
S. Geraldo and P. R. Gordon-Weeks
Cytoskeletal dynamics in growth-cone steering
J. Cell Sci.,
October 15, 2009;
122(20):
3595 - 3604.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Shintani, M. Ihara, S. Tani, J. Sakuraba, H. Sakuta, and M. Noda
APC2 Plays an Essential Role in Axonal Projections through the Regulation of Microtubule Stability
J. Neurosci.,
September 16, 2009;
29(37):
11628 - 11640.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Mimura, S. Yamagishi, N. Arimura, M. Fujitani, T. Kubo, K. Kaibuchi, and T. Yamashita
Myelin-associated Glycoprotein Inhibits Microtubule Assembly by a Rho-kinase-dependent Mechanism
J. Biol. Chem.,
June 9, 2006;
281(23):
15970 - 15979.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Rajnicek, L. E. Foubister, and C. D. McCaig
Growth cone steering by a physiological electric field requires dynamic microtubules, microfilaments and Rac-mediated filopodial asymmetry
J. Cell Sci.,
May 1, 2006;
119(9):
1736 - 1745.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Lemons, S. Barua, M. L. Abanto, W. Halfter, and M. L. Condic
Adaptation of Sensory Neurons to Hyalectin and Decorin Proteoglycans
J. Neurosci.,
May 18, 2005;
25(20):
4964 - 4973.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Trivedi, P. Marsh, R. G. Goold, A. Wood-Kaczmar, and P. R. Gordon-Weeks
Glycogen synthase kinase-3{beta} phosphorylation of MAP1B at Ser1260 and Thr1265 is spatially restricted to growing axons
J. Cell Sci.,
March 1, 2005;
118(5):
993 - 1005.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Bouquet, S. Soares, Y. von Boxberg, M. Ravaille-Veron, F. Propst, and F. Nothias
Microtubule-Associated Protein 1B Controls Directionality of Growth Cone Migration and Axonal Branching in Regeneration of Adult Dorsal Root Ganglia Neurons
J. Neurosci.,
August 11, 2004;
24(32):
7204 - 7213.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Turner, S. Nicholls, and A. Hall
The Activity of the Plexin-A1 Receptor Is Regulated by Rac
J. Biol. Chem.,
August 6, 2004;
279(32):
33199 - 33205.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. H. Suh, S. F. Oster, S. S. Soehrman, G. Grenningloh, and D. W. Sretavan
L1/Laminin Modulation of Growth Cone Response to EphB Triggers Growth Pauses and Regulates the Microtubule Destabilizing Protein SCG10
J. Neurosci.,
February 25, 2004;
24(8):
1976 - 1986.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. B. Buck and J. Q. Zheng
Growth Cone Turning Induced by Direct Local Modification of Microtubule Dynamics
J. Neurosci.,
November 1, 2002;
22(21):
9358 - 9367.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. W. Schaefer, N. Kabir, and P. Forscher
Filopodia and actin arcs guide the assembly and transport of two populations of microtubules with unique dynamic parameters in neuronal growth cones
J. Cell Biol.,
July 8, 2002;
158(1):
139 - 152.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F.-Q. Zhou, C. M. Waterman-Storer, and C. S. Cohan
Focal loss of actin bundles causes microtubule redistribution and growth cone turning
J. Cell Biol.,
May 28, 2002;
157(5):
839 - 849.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. B. Nixon, G. Grenningloh, and P. J. Casey
The Interaction of RGSZ1 with SCG10 Attenuates the Ability of SCG10 to Promote Microtubule Disassembly
J. Biol. Chem.,
May 10, 2002;
277(20):
18127 - 18133.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Kim, P. Kolodziej, and A. Chiba
Growth Cone Pathfinding and Filopodial Dynamics Are Mediated Separately by Cdc42 Activation
J. Neurosci.,
March 1, 2002;
22(5):
1794 - 1806.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. W. Dent and K. Kalil
Axon Branching Requires Interactions between Dynamic Microtubules and Actin Filaments
J. Neurosci.,
December 15, 2001;
21(24):
9757 - 9769.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Kabir, A. W. Schaefer, A. Nakhost, W. S. Sossin, and P. Forscher
Protein Kinase C Activation Promotes Microtubule Advance in Neuronal Growth Cones by Increasing Average Microtubule Growth Lifetimes
J. Cell Biol.,
March 5, 2001;
152(5):
1033 - 1044.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kamiguchi and V. Lemmon
Recycling of the Cell Adhesion Molecule L1 in Axonal Growth Cones
J. Neurosci.,
May 15, 2000;
20(10):
3676 - 3686.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Condic, D. M. Snow, and P. C. Letourneau
Embryonic Neurons Adapt to the Inhibitory Proteoglycan Aggrecan by Increasing Integrin Expression
J. Neurosci.,
November 15, 1999;
19(22):
10036 - 10043.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Gallo and P. C. Letourneau
Different Contributions of Microtubule Dynamics and Transport to the Growth of Axons and Collateral Sprouts
J. Neurosci.,
May 15, 1999;
19(10):
3860 - 3873.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Goold, R Owen, and P. Gordon-Weeks
Glycogen synthase kinase 3beta phosphorylation of microtubule-associated protein 1B regulates the stability of microtubules in growth cones
J. Cell Sci.,
January 10, 1999;
112(19):
3373 - 3384.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Prokop, J. Uhler, J. Roote, and M. Bate
The kakapo Mutation Affects Terminal Arborization and Central Dendritic Sprouting of Drosophila Motorneurons
J. Cell Biol.,
November 30, 1998;
143(5):
1283 - 1294.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Zakharenko and S. Popov
Dynamics of Axonal Microtubules Regulate the Topology of New Membrane Insertion into the Growing Neurites
J. Cell Biol.,
November 16, 1998;
143(4):
1077 - 1086.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Tint, T. Slaughter, I. Fischer, and M. M. Black
Acute Inactivation of Tau Has No Effect on Dynamics of Microtubules in Growing Axons of Cultured Sympathetic Neurons
J. Neurosci.,
November 1, 1998;
18(21):
8660 - 8673.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Sawin and P. Nurse
Regulation of Cell Polarity by Microtubules in Fission Yeast
J. Cell Biol.,
July 27, 1998;
142(2):
457 - 471.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kinnunen, M. Kaksonen, J. Saarinen, N. Kalkkinen, H. B. Peng, and H. Rauvala
Cortactin-Src Kinase Signaling Pathway Is Involved in N-syndecan-dependent Neurite Outgrowth
J. Biol. Chem.,
April 24, 1998;
273(17):
10702 - 10708.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Suter, L. D. Errante, V. Belotserkovsky, and P. Forscher
The Ig Superfamily Cell Adhesion Molecule, apCAM, Mediates Growth Cone Steering by Substrate-Cytoskeletal Coupling
J. Cell Biol.,
April 6, 1998;
141(1):
227 - 240.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Antonsson, D. B. Kassel, G. Di Paolo, R. Lutjens, B. M. Riederer, and G. Grenningloh
Identification of in Vitro Phosphorylation Sites in the Growth Cone Protein SCG10. EFFECT OF PHOSPHORYLATION SITE MUTANTS ON MICROTUBULE-DESTABILIZING ACTIVITY
J. Biol. Chem.,
April 3, 1998;
273(14):
8439 - 8446.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A Rajnicek and C McCaig
Guidance of CNS growth cones by substratum grooves and ridges: effects of inhibitors of the cytoskeleton, calcium channels and signal transduction pathways
J. Cell Sci.,
January 12, 1997;
110(23):
2915 - 2924.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Gu and Y. Ihara
Evidence That Collapsin Response Mediator Protein-2 Is Involved in the Dynamics of Microtubules
J. Biol. Chem.,
June 9, 2000;
275(24):
17917 - 17920.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|